Please assess the completion status of the following clinical trial:

Trial Title: The Effect of Losartan and Losartan Plus Isosorbide Mononitrate on Central Blood Pressure Measurements (0954-317)

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: CROSSOVER
- Observational Model: None
- Primary Purpose: DIAGNOSTIC
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE1
- Number of Arms: 5.0

Eligibility Criteria:
Inclusion Criteria:~* Patient is in good health with the exception of mild to moderate hypertension~* Patient is willing to comply with the study restrictions~* Patient does not smoke~Exclusion Criteria:~* Patient has a history of any illness that might confound the results of the study or make participation in the study unsafe~* Patient is taking a prescription medication that is contraindicated for use with COZAAR® or IMDUR®~* Patient has a condition for which there is a warning, contraindication, or precaution against the use of COZAAR® or IMDUR®

- Gender: ALL
- Minimum Age: 45 Years
- Maximum Age: 70 Years
- Healthy Volunteers: f

Study Arms:
- 1 (Type: ACTIVE_COMPARATOR): losartan 100 mg
- 2 (Type: ACTIVE_COMPARATOR): ISMN 60 mg
- 3 (Type: ACTIVE_COMPARATOR): losartan 100 mg + ISMN 15 mg
- 4 (Type: ACTIVE_COMPARATOR): losartan 100 mg + ISMN 60 mg
- 5 (Type: PLACEBO_COMPARATOR): Placebo

Based on this trial design, predict the completion outcome and termination type (if applicable).